Anti-interleukin-17A biologics for the long-term treatment of bullous pemphigoid: A prospective, cohort study

J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e749-e751. doi: 10.1111/jdv.18907. Epub 2023 Jan 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Products* / therapeutic use
  • Cohort Studies
  • Humans
  • Pemphigoid, Bullous* / drug therapy
  • Prospective Studies

Substances

  • Biological Products
  • IL17A protein, human